HTLF Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$259K Sell
2,809
-47
-2% -$4.23K 0.03% 184
2024
Q3
$239K Sell
2,856
-397
-12% -$30.3K 0.03% 197
2024
Q2
$223K Buy
3,253
+130
+4% +$8.68K 0.03% 217
2024
Q1
$229K Buy
3,123
+3
+0.1% +$231 0.03% 211
2023
Q4
$253K Buy
+3,120
New +$243K 0.03% 192

Other funds holding GILD

HTLF Bank's GILD Position: Q4 2024 in Review

HTLF Bank reduced its Gilead Sciences (GILD) stake by 1.6% in Q4 2024, selling an estimated $4.23K and leaving 2,809 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #184.

HTLF Bank first reported a position in GILD in Q4 2023 and has held it in 5 quarters since. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • HTLF Bank held 2,809 shares of Gilead Sciences worth $259K as of Q4 2024.
  • HTLF Bank sold 47 Gilead Sciences shares in Q4 2024, an estimated $4.23K.
  • Gilead Sciences made up 0.03% of HTLF Bank's portfolio in Q4 2024, its #184 holding.
  • HTLF Bank first reported a position in Gilead Sciences in Q4 2023 and has held it in 5 quarters since.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on HTLF Bank's 13F filing for Q4 2024, filed 28 Jan 2025.